4
Changes in Ownership
ArriVent BioPharma, Inc. Filed Acc 0001104659-24-102146
Chief Operating Officer acquired 27,566 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
LaChapelle Robin · Chief Operating Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-09-19 | Exercise or conversion : show line 1 in the form | +2,700 | $6.24 | $16,848 | 99,717 | D |
| 2024-09-19 | Exercise or conversion : show line 2 in the form | +2,867 | $2.28 | $6,537 | 102,584 | D |
| 2024-09-19 | Exercise or conversion : show line 3 in the form | +7,164 | $2.28 | $16,334 | 109,748 | D |
| 2024-09-19 | Exercise or conversion : show line 4 in the form | +2,471 | $2.28 | $5,634 | 112,219 | D |
| 2024-09-19 | Exercise or conversion : show line 5 in the form | +12,364 | $3.65 | $45,129 | 124,583 | D |
Table II: Derivative
5 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-09-19 | Exercise or conversion : show line 6 in the form Stock Option (right to buy) | −2,471 | 2,460 | D |
| 2024-09-19 | Exercise or conversion : show line 7 in the form Stock Option (right to buy) | −2,867 | 22,637 | D |
| 2024-09-19 | Exercise or conversion : show line 8 in the form Stock Option (right to buy) | −7,164 | 15,473 | D |
| 2024-09-19 | Exercise or conversion : show line 9 in the form Stock Option (right to buy) | −12,364 | 18,865 | D |
| 2024-09-19 | Exercise or conversion : show line 10 in the form Stock Option (right to buy) | −2,700 | 56,471 | D |
Loading xslF345X05/tm2424588-1_4seq1.xml…